Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE mTOR inhibitors are currently used as immunosuppressants in transplanted patients and as promising anti‐cancer agents. However, new‐onset diabetes is a frequent complication occurring in patients treated with mTOR inhibitors such as rapamycin (Sirolimus). Here, we investigated the mechanisms associated with the diabetogenic effects of chronic Sirolimus administration in rats and in in vitro cell cultures. EXPERIMENTAL APPROACH Sirolimus was administered to rats fed either a standard or high‐fat diet for 21 days. Metabolic parameters were measured in vivo and in ex vivo tissues. Insulin sensitivity was assessed by glucose tolerance tests and euglycaemic hyperinsulinaemic clamps. Rapamycin effects on glucose metabolism and insulin signalling were further evaluated in cultured myotubes. KEY RESULTS Sirolimus induced a decrease in food intake and concomitant weight loss. It also induced specific fat mass loss that was independent of changes in food intake. Despite these beneficial effects, Sirolimus‐treated rats were glucose intolerant, hyperinsulinaemic and hyperglycaemic, but not hyperlipidaemic. The euglycaemic hyperinsulinaemic clamp measurements showed skeletal muscle is a major site of Sirolimus‐induced insulin resistance. At the molecular level, long‐term Sirolimus administration attenuated glucose uptake and metabolism in skeletal muscle by preventing full insulin‐induced Akt activation and altering the expression and translocation of glucose transporters to the plasma membrane. In rats fed a high‐fat diet, these metabolic defects were exacerbated, although Sirolimus‐treated animals were protected from diet‐induced obesity. CONCLUSIONS AND IMPLICATIONS Taken together, our data demonstrate that the diabetogenic effect of chronic rapamycin administration is due to an impaired insulin action on glucose metabolism in skeletal muscles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488 · cited 4×
“, 2007), but whether such defects affect insulin sensitivity and glucose tolerance remain controversial (Wredenberg et al., 2006; Cunningham et al., 2007; Pospisilik et al., 2007).”
BackgroundInfluentialGlucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
Wood, I. S., & Trayhurn, P. (2003) · British Journal of Nutrition · doi:10.1079/bjn2002763 · Cited by 889 · cited 1×
“More specifically, GLUT1 mediates basal glucose transport, whereas GLUT4 is responsible for insulin-stimulated glucose uptake (Wood and Trayhurn, 2003).”
BackgroundNutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1
Um, S. H., D'Alessio, D., & Thomas, G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.003 · Cited by 690
Adipose-Specific Knockout of raptor Results in Lean Mice with Enhanced Mitochondrial Respiration
Polak, P., Cybulski, N., Feige, J. N., Auwerx, J., Rüegg, M. A., & Hall, M. N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.003 · Cited by 480 · cited 1×
“…reported that rapamycin, or deletion of a component of the mTOR complexes, stimulates lipolysis and/or prevents lipogenesis in white adipose cells (Polak et al., 2008; Chakra- Table 2 Plasma TG and NEFA in rats fed a high fat diet Vehicle Vehicle Sirolimus PF Standard diet HF diet HF diet HF…”
BackgroundTremblay, F., Brûlé, S., Hee Um, S., Li, Y., Masuda, K., Roden, M., Sun, X. J., Krebs, M., Polakiewicz, R. D., Thomas, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706517104 · Cited by 465 · cited 1×
“This is particularly intriguing since acute administration of rapamycin was shown to improve insulin signalling and glucose uptake in muscle and adipose cells exposed to an excess of nutrients (Tzatsos and Kandror, 2006; Tremblay et al., 2007).”
BackgroundHoude, V. P., Brûlé, S., Festuccia, W. T., Blanchard, P.-G., Bellmann, K., Deshaies, Y., & Marette, A. (2010) · Diabetes · doi:10.2337/db09-1324 · Cited by 456 · cited 13×
“Hyperlipidaemia, potentially resulting from increased adipose tissue lipolysis or hepatic TG synthesis, has been suggested to represent one of the factors contributing to peripheral insulin resistance following systemic mTOR inhibition (Morrisett et al., 2002; Chakrabarti et al., 2010; Houde et al., 2010; Kumar et al.…”
BackgroundResultInfluentialPospisilik, J. A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P. D., Ebersberger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.047 · Cited by 404 · cited 2×
“, 2007), but whether such defects affect insulin sensitivity and glucose tolerance remain controversial (Wredenberg et al., 2006; Cunningham et al., 2007; Pospisilik et al., 2007).”
BackgroundTzatsos, A., & Kandror, K. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.63-76.2006 · Cited by 399
Morrisett, J. D., Abdel-Fattah, G., Hoogeveen, R., Mitchell, E., Ballantyne, C. M., Pownall, H. J., Opekun, A. R., Jaffe, J. S., Oppermann, S., & Kahan, B. D. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100392-jlr200 · Cited by 295 · cited 2×
“…resulting from increased adipose tissue lipolysis or hepatic TG synthesis, has been suggested to represent one of the factors contributing to peripheral insulin resistance following systemic mTOR inhibition (Morrisett et al., 2002; Chakrabarti et al., 2010; Houde et al., 2010; Kumar et al., 2010).”
BackgroundVinciguerra, M., Sgroi, A., Veyrat-Durebex, C., Rubbia-Brandt, L., Buhler, L. H., & Foti, M. (2009) · Hepatology · doi:10.1002/hep.22737 · Cited by 198 · cited 1×
“On the other hand, as regards the liver, we previously showed that free fatty acids trigger insulin resistance and steatosis in hepatocytes by down-regulating PTEN expression through mTOR-dependent mechanisms (Vinciguerra et al., 2008; 2009).”
BackgroundSelf-citation
Cited by
The aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
Epigenetic regulation of aging: implications for interventions of aging and diseases
Wang, K., Liu, H., Hu, Q., Wang, L., Liu, J., Zheng, Z., Zhang, W., Ren, J., Zhu, F., & Liu, G.-H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01211-8 · Cited by 663
The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet
Mitchell, S. J., Martin-Montalvo, A., Mercken, E. M., Palacios, H. H., Ward, T. M., Abulwerdi, G., Minor, R. K., Vlasuk, G. P., Ellis, J. L., Sinclair, D. A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.031 · Cited by 398
Rapamycin extends murine lifespan but has limited effects on aging
Neff, F., Flores-Dominguez, D., Ryan, D. P., Horsch, M., Schröder, S., Adler, T., Afonso, L. C., Aguilar-Pimentel, J. A., Becker, L., Garrett, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67674 · Cited by 374
Role of mTOR in Glucose and Lipid Metabolism
Mao, Z., & Zhang, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072043 · Cited by 296
Metadata
- Authors
- Deblon, N., Bourgoin, L., Veyrat‐Durebex, C., Peyrou, M., Vinciguerra, M., Caillon, A., Maeder, C., Fournier, M., Montet, X., Rohner‐Jeanrenaud, F., & Foti, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-03-09
- Volume
- 165
- Issue
- 7
- Pages
- 2325-2340
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1488364563
- Cited by
- 154
- References
- 11
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01716.x
- The paper
- Deblon, N., Bourgoin, L., Veyrat‐Durebex, C., Peyrou, M., Vinciguerra, M., Caillon, A., Maeder, C., Fournier, M., Montet, X., Rohner‐Jeanrenaud, F., & Foti, M. (2012). Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01716.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.